MacroGenics reports four responses among 16 evaluable clear cell cancer patients, with lower-dose lorigerlimab results ...
Single agent lorigerlimab demonstrated encouraging preliminary clinical activity in clear cell gynecologic cancer (CCGC) with a confirmed ORR of ...
ZW191 demonstrates compelling anti-tumor activity in heavily pretreated patients with platinum-resistant ovarian cancer ...
BioInvent reported updated Phase 1/2 data from Part B of its ongoing study of BI-1808 combined with pembrolizumab in heavily pretreated, platinum-resistant recurrent ovarian cancer, showing a 24% ...
Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work ...
HRDPath, an AI model, analyzes tissue images to identify ovarian cancers with homologous recombination deficiency.
The investigational folate receptor alpha (FRα)–targeted antibody-drug conjugate (ADC) sofetabart mipitecan (LY4170156) ...
An AI model created by researchers at King's can detect signs of faulty repair mechanisms in ovarian cancer cells, potentially leading to a low-cost ...
An AI model created by researchers at King's can detect signs of faulty repair mechanisms in ovarian cancer cells, potentially leading to a low-cost, widely accessible diagnostic tool in the future.
Reduced Surgical Morbidity in Endometrial Cancer Staging / ALICE Trial, Brazil, cancer, Endometrial cancer, IGCS2026, Lymphadenectomy ...
A retrospective single-center cohort of 128 patients associated frontline bevacizumab with longer overall survival in ...
Indocyanine green may be highly sensitive in the identification of ovarian cancer metastases, though with low specificity. One method used for intraoperative tissue imaging is indocyanine green (ICG).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results